Variable | Total | Survivors | Non-survivors | P value |
---|---|---|---|---|
Patients | 185 (100.0) | 99 (53.5) | 86 (46.5) | |
Age, years | 47 (18.2) | 43 (17.4) | 51 (18.3) | 0.003 |
Men | 128 (69.2) | 74 (74.7) | 54 (62.8) | 0.079 |
APACHE II, score | 16 (1–37) | 12 (1–30) | 21 (9–37) | <0.001 |
SOFA, score | 6 (0–20) | 5 (0–14) | 9 (2–20) | <0.001 |
Predicted mortality, % | 25 (4–85) | 15 (4–75) | 40 (9–85) | <0.001 |
Comorbidities | ||||
DM2 | 58 (31.4) | 23 (23.2) | 35 (40.7) | 0.011 |
Ischemic cardiopathy | 24 (13.0) | 12 (12.1) | 12 (14.0) | 0.711 |
Chronic nephropathy | 23 (12.4) | 5 (5.1) | 18 (20.9) | 0.001 |
Chronic liver disease | 7 (3.8) | 2 (2.0) | 5 (5.8) | 0.265 |
Chronic pneumopathy | 7 (3.8) | 4 (4.0) | 3 (3.5) | 1.000 |
Blood neoplasia | 1 (0.5) | 1 (1.0) | 0 (0.0) | 1.000 |
Solid neoplasia | 15 (8.1) | 4 (4.4) | 11 (12.8) | 0.030 |
HIV infection | 5 (2.7) | 1 (1.0) | 4 (4.7) | 0.285 |
ICU admission diagnosis | ||||
Medical | 87 (47.0) | 37 (37.4) | 50 (58.1) | 0.005 |
Surgical, urgent | 40 (21.6) | 19 (19.2) | 21 (24.4) | 0.389 |
Surgical, elective | 25 (13.5) | 21 (21.2) | 4 (4.7) | 0.001 |
Trauma | 33 (17.8) | 22 (22.2) | 11 (12.8) | 0.095 |
ICU admission eosinophils count, K/μL | 0.013 (0.0–0.578) | 0.014 (0.0–0.363) | 0.010 (0.0–0.578) | 0.355 |
Hospital stay, days | 14 (2–96) | 18 (3–96) | 11.5 (2–56) | 0.007 |
ICU stay, days | 6 (1–46) | 5 (1–28) | 7.5 (1–46) | 0.004 |